This criteria set has been approved by the American College of Rheumatology (ACR) Board of Directors as Provisional. This signifies that the criteria set has been quantitatively validated using patient data, but it has not undergone validation based on an external data set. All ACR-approved criteria sets are expected to undergo intermittent updates.
Article first published online: 28 FEB 2007
Copyright © 2007 by the American College of Rheumatology
Arthritis Care & Research
Volume 57, Issue 2, pages 203–212, 15 March 2007
How to Cite
Zulian, F., Woo, P., Athreya, B. H., Laxer, R. M., Medsger, T. A., Lehman, T. J. A., Cerinic, M. M., Martini, G., Ravelli, A., Russo, R., Cuttica, R., de Oliveira, S. K. F., Denton, C. P., Cozzi, F., Foeldvari, I., Ruperto, N. and Pediatric Rheumatology European Society/American College of Rheumatology/European League Against Rheumatism Ad Hoc Committee on classification criteria for juvenile systemic sclerosis (2007), The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis & Rheumatism, 57: 203–212. doi: 10.1002/art.22551
The American College of Rheumatology is an independent, professional, medical, and scientific society, which does not guarantee, warrant, or endorse any commercial product or service.
- Issue published online: 28 FEB 2007
- Article first published online: 28 FEB 2007
- Manuscript Accepted: 19 OCT 2006
- Manuscript Received: 17 MAY 2006
- Il Volo Association for Childhood Rheumatic Diseases and the Veneto Region
- Systemic sclerosis;
- Classification criteria;
- Organ involvement
To develop criteria for the classification of systemic sclerosis (SSc) in children (juvenile SSc).
The study consisted of 3 phases: 1) collection of data on the signs and symptoms of actual patients with juvenile SSc that are useful for defining involvement of a particular organ; 2) selection of the parameters essential for the classification of juvenile SSc and preparation of a set of provisional classification criteria (PCC) using 2 Delphi surveys; 3) consensus conference consisting of 2 steps: discussion and rating of clinical profiles of 160 patients with definite juvenile SSc, possible juvenile SSc, or other fibrosing diseases as “having or not having juvenile SSc,” using nominal group technique, and defining those PCC with the best statistical performance and highest face validity by using the clinical profiles of patients with definite juvenile SSc as the gold standard.
In phase 1, 55 centers submitted clinical data on 153 patients with juvenile SSc. A total of 48 signs and symptoms were derived from these patient data and were used to define 9 organ system categories (cutaneous, vascular, gastrointestinal, respiratory, renal, cardiac, neurologic, musculoskeletal, and serologic). During phase 2, these were reduced to 21 criteria (3 major criteria [Raynaud's phenomenon, proximal skin sclerosis/induration of the skin, and sclerodactyly] and 18 minor criteria) and combined to generate 86 different PCC. At the consensus conference, these 86 definitions were tested on the case profiles of 127 patients with juvenile SSc. The PCC with the highest ranking were proximal sclerosis/induration and at least 2 minor criteria.
These provisional classification criteria for juvenile SSc will help standardize the conduct of clinical research, epidemiologic and outcome studies, and therapeutic trials.